Logo image of ALHRG.PA

HERIGE (ALHRG.PA) Stock Fundamental Analysis

EPA:ALHRG - Euronext Paris - Matif - FR0000066540 - Common Stock - Currency: EUR

22.4  -0.8 (-3.45%)

Fundamental Rating

4

ALHRG gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 16 industry peers in the Trading Companies & Distributors industry. ALHRG has an average financial health and profitability rating. ALHRG has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ALHRG was profitable.
In the past year ALHRG had a positive cash flow from operations.
ALHRG had positive earnings in each of the past 5 years.
Each year in the past 5 years ALHRG had a positive operating cash flow.
ALHRG.PA Yearly Net Income VS EBIT VS OCF VS FCFALHRG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

1.2 Ratios

With a decent Return On Assets value of 3.19%, ALHRG is doing good in the industry, outperforming 62.50% of the companies in the same industry.
The Return On Equity of ALHRG (7.28%) is better than 68.75% of its industry peers.
Industry RankSector Rank
ROA 3.19%
ROE 7.28%
ROIC N/A
ROA(3y)3.05%
ROA(5y)3.17%
ROE(3y)9.8%
ROE(5y)10.93%
ROIC(3y)N/A
ROIC(5y)N/A
ALHRG.PA Yearly ROA, ROE, ROICALHRG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

ALHRG has a Profit Margin (2.08%) which is in line with its industry peers.
In the last couple of years the Profit Margin of ALHRG has grown nicely.
ALHRG has a Gross Margin of 48.17%. This is amongst the best in the industry. ALHRG outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of ALHRG has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 2.08%
GM 48.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-8.18%
PM growth 5Y11.63%
GM growth 3Y5.76%
GM growth 5Y4.96%
ALHRG.PA Yearly Profit, Operating, Gross MarginsALHRG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

ALHRG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALHRG has been increased compared to 1 year ago.
The number of shares outstanding for ALHRG has been reduced compared to 5 years ago.
The debt/assets ratio for ALHRG has been reduced compared to a year ago.
ALHRG.PA Yearly Shares OutstandingALHRG.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
ALHRG.PA Yearly Total Debt VS Total AssetsALHRG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

An Altman-Z score of 2.64 indicates that ALHRG is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.64, ALHRG perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
The Debt to FCF ratio of ALHRG is 10.48, which is on the high side as it means it would take ALHRG, 10.48 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 10.48, ALHRG is in line with its industry, outperforming 50.00% of the companies in the same industry.
ALHRG has a Debt/Equity ratio of 0.66. This is a neutral value indicating ALHRG is somewhat dependend on debt financing.
ALHRG's Debt to Equity ratio of 0.66 is on the low side compared to the rest of the industry. ALHRG is outperformed by 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 10.48
Altman-Z 2.64
ROIC/WACCN/A
WACC5.61%
ALHRG.PA Yearly LT Debt VS Equity VS FCFALHRG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

ALHRG has a Current Ratio of 2.46. This indicates that ALHRG is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.46, ALHRG is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
ALHRG has a Quick Ratio of 1.97. This is a normal value and indicates that ALHRG is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ALHRG (1.97) is better than 93.75% of its industry peers.
Industry RankSector Rank
Current Ratio 2.46
Quick Ratio 1.97
ALHRG.PA Yearly Current Assets VS Current LiabilitesALHRG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.08% over the past year.
The Earnings Per Share has been growing by 8.13% on average over the past years. This is quite good.
Looking at the last year, ALHRG shows a very negative growth in Revenue. The Revenue has decreased by -37.09% in the last year.
ALHRG shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.31% yearly.
EPS 1Y (TTM)15.08%
EPS 3Y-17.2%
EPS 5Y8.13%
EPS Q2Q%-2286.12%
Revenue 1Y (TTM)-37.09%
Revenue growth 3Y-9.62%
Revenue growth 5Y-3.31%
Sales Q2Q%-49.96%

3.2 Future

The Earnings Per Share is expected to decrease by -30.87% on average over the next years. This is quite bad
The Revenue is expected to decrease by -21.69% on average over the next years. This is quite bad
EPS Next Y-119.56%
EPS Next 2Y-30.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y-25.44%
Revenue Next 3Y-21.69%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALHRG.PA Yearly Revenue VS EstimatesALHRG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 2027 200M 400M 600M 800M
ALHRG.PA Yearly EPS VS EstimatesALHRG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 6.02, the valuation of ALHRG can be described as very cheap.
Based on the Price/Earnings ratio, ALHRG is valued cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.32, ALHRG is valued rather cheaply.
The Forward Price/Earnings Ratio is negative for ALHRG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 6.02
Fwd PE N/A
ALHRG.PA Price Earnings VS Forward Price EarningsALHRG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALHRG is valued cheaper than 100.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ALHRG is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.1
EV/EBITDA 2.56
ALHRG.PA Per share dataALHRG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

ALHRG's earnings are expected to decrease with -30.87% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.74
EPS Next 2Y-30.87%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALHRG!.
Industry RankSector Rank
Dividend Yield N/A

HERIGE

EPA:ALHRG (6/17/2025, 7:00:00 PM)

22.4

-0.8 (-3.45%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)05-12 2025-05-12
Earnings (Next)07-21 2025-07-21
Inst Owners1.65%
Inst Owner ChangeN/A
Ins Owners18%
Ins Owner ChangeN/A
Market Cap66.98M
Analysts84.44
Price Target31.62 (41.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.88
Dividend Growth(5Y)20.75%
DP49.37%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8.82%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-116.42%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.02
Fwd PE N/A
P/S 0.13
P/FCF 7.1
P/OCF 2.73
P/B 0.45
P/tB 0.62
EV/EBITDA 2.56
EPS(TTM)3.72
EY16.61%
EPS(NY)-1.37
Fwd EYN/A
FCF(TTM)3.15
FCFY14.08%
OCF(TTM)8.19
OCFY36.58%
SpS175.82
BVpS50.19
TBVpS36.35
PEG (NY)N/A
PEG (5Y)0.74
Profitability
Industry RankSector Rank
ROA 3.19%
ROE 7.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2.08%
GM 48.17%
FCFM 1.79%
ROA(3y)3.05%
ROA(5y)3.17%
ROE(3y)9.8%
ROE(5y)10.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-8.18%
PM growth 5Y11.63%
GM growth 3Y5.76%
GM growth 5Y4.96%
F-Score8
Asset Turnover1.53
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 10.48
Debt/EBITDA 3.87
Cap/Depr 38.38%
Cap/Sales 2.87%
Interest Coverage N/A
Cash Conversion 96%
Profit Quality 86.26%
Current Ratio 2.46
Quick Ratio 1.97
Altman-Z 2.64
F-Score8
WACC5.61%
ROIC/WACCN/A
Cap/Depr(3y)88.52%
Cap/Depr(5y)109.83%
Cap/Sales(3y)3.05%
Cap/Sales(5y)3.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.08%
EPS 3Y-17.2%
EPS 5Y8.13%
EPS Q2Q%-2286.12%
EPS Next Y-119.56%
EPS Next 2Y-30.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-37.09%
Revenue growth 3Y-9.62%
Revenue growth 5Y-3.31%
Sales Q2Q%-49.96%
Revenue Next YearN/A
Revenue Next 2Y-25.44%
Revenue Next 3Y-21.69%
Revenue Next 5YN/A
EBIT growth 1Y-164.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y-2.55%
EBIT Next 5YN/A
FCF growth 1Y221.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y44.23%
OCF growth 3Y34.8%
OCF growth 5Y-4.32%